These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29704625)

  • 1. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
    Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
    Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4* and α9α10 subtypes.
    Arias HR; Jin XT; Gallino S; Peng C; Feuerbach D; García-Colunga J; Elgoyhen AB; Drenan RM; Ortells MO
    Neurochem Int; 2019 Dec; 131():104552. PubMed ID: 31545995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
    Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
    Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus.
    Vázquez-Gómez E; Arias HR; Feuerbach D; Miranda-Morales M; Mihailescu S; Targowska-Duda KM; Jozwiak K; García-Colunga J
    Eur J Pharmacol; 2014 Oct; 740():103-11. PubMed ID: 25016090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
    Gumilar F; Bouzat C
    Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Russell M; Jozwiak K
    Biochemistry; 2010 Jul; 49(27):5734-42. PubMed ID: 20527991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
    Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
    Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
    Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
    ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Classes of Antidepressants Inhibit the Rat α7 Nicotinic Acetylcholine Receptor by Interacting within the Ion Channel: A Functional and Structural Study.
    Duarte Y; Rojas M; Canan J; Pérez EG; González-Nilo F; García-Colunga J
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33668529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.
    Gumilar F; Arias HR; Spitzmaul G; Bouzat C
    Neuropharmacology; 2003 Dec; 45(7):964-76. PubMed ID: 14573389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.
    Arias HR; Feuerbach D; Schmidt B; Heydenreich M; Paz C; Ortells MO
    J Nat Prod; 2018 Apr; 81(4):811-817. PubMed ID: 29634269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
    Arias HR; Jin X; Feuerbach D; Drenan RM
    Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Ortells MO
    Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
    Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
    Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
    Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
    López-Valdés HE; García-Colunga J
    Mol Psychiatry; 2001 Sep; 6(5):511-9. PubMed ID: 11526465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
    Arias HR; Ravazzini F; Targowska-Duda KM; Kaczor AA; Feuerbach D; Boffi JC; Draczkowski P; Montag D; Brown BM; Elgoyhen AB; Jozwiak K; Puia G
    Int J Biochem Cell Biol; 2016 Jul; 76():19-30. PubMed ID: 27129924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.